Laboratory of Pediatric Nephrology, Department of Development and Regeneration, KU Leuven Campus Gasthuisberg, 3000 Leuven, Belgium.
Department of Pediatrics, AZ Delta Campus Torhout, 8820 Torhout, Belgium.
Int J Mol Sci. 2023 Jan 9;24(2):1253. doi: 10.3390/ijms24021253.
Cystinosis is an autosomal recessive lysosomal storage disease, caused by mutations in the CTNS gene, resulting in multi-organ cystine accumulation. Three forms of cystinosis are distinguished: infantile and juvenile nephropathic cystinosis affecting kidneys and other organs such as the eyes, endocrine system, muscles, and brain, and adult ocular cystinosis affecting only the eyes. Currently, elevated white blood cell (WBC) cystine content is the gold standard for the diagnosis of cystinosis. We present a patient with proteinuria at adolescent age and corneal cystine crystals, but only slightly elevated WBC cystine levels (1.31 ½ cystine/mg protein), precluding the diagnosis of nephropathic cystinosis. We demonstrate increased levels of cystine in skin fibroblasts and urine-derived kidney cells (proximal tubular epithelial cells and podocytes), that were higher than the values observed in the WBC and healthy control. CTNS gene analysis shows the presence of a homozygous missense mutation (c.590 A > G; p.Asn177Ser), previously described in the Arab population. Our observation underlines that low WBC cystine levels can be observed in patients with juvenile cystinosis, which may delay the diagnosis and timely administration of cysteamine. In such patients, the diagnosis can be confirmed by cystine measurement in slow-dividing cells and by molecular analysis of the CTNS gene.
胱氨酸病是一种常染色体隐性溶酶体贮积病,由 CTNS 基因突变引起,导致多器官胱氨酸蓄积。胱氨酸病分为三种类型:婴儿型和青少年型肾性胱氨酸病影响肾脏和其他器官,如眼睛、内分泌系统、肌肉和大脑,以及成人眼型胱氨酸病仅影响眼睛。目前,白细胞(WBC)胱氨酸含量升高是胱氨酸病诊断的金标准。我们报告了一名青少年蛋白尿和角膜胱氨酸晶体患者,但仅略高的 WBC 胱氨酸水平(1.31 ½ 胱氨酸/mg 蛋白),排除了肾性胱氨酸病的诊断。我们在皮肤成纤维细胞和尿源性肾细胞(近端肾小管上皮细胞和足细胞)中观察到胱氨酸水平升高,高于 WBC 和健康对照组观察到的水平。CTNS 基因突变分析显示存在纯合错义突变(c.590 A > G;p.Asn177Ser),以前在阿拉伯人群中报道过。我们的观察结果强调,青少年型胱氨酸病患者可能会出现白细胞胱氨酸水平较低的情况,这可能会延迟诊断和及时给予半胱氨酸。在这些患者中,可以通过对慢分裂细胞的胱氨酸测量和 CTNS 基因突变的分子分析来确认诊断。